We are live on
!
Find out more
SP
Solel Partners Portfolio holdings
AUM
$468M
1-Year Est. Return
2.45%
This Fund
S&P 500
This Quarter
Est. Return
+15.47%
1 Year Est. Return
+2.45%
3 Year Est. Return
+16.25%
5 Year Est. Return
+25.79%
10 Year Est. Return
–
AUM
$264M
AUM Growth
+$59.5M
(+29%)
Cap. Flow
+$31.8M
Cap. Flow
% of AUM
12.05%
Top 10 Holdings %
Top 10 Hldgs %
86.31%
Holding
19
New
7
Increased
2
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Universal Health Services
UHS
|
+$24.1M |
| 2 |
Ambev
ABEV
|
+$17.5M |
| 3 |
Fomento Económico Mexicano
FMX
|
+$17.5M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$13.7M |
| 5 |
HDFC Bank
HDB
|
+$12.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$39.6M |
| 2 |
DNKN
Dunkin' Brands Group, Inc.
DNKN
|
+$11.8M |
| 3 |
HCA Healthcare
HCA
|
+$4.79M |
| 4 |
AerCap
AER
|
+$4.51M |
| 5 |
Wyndham Hotels & Resorts
WH
|
+$1.85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.69% |
| 2 | Consumer Discretionary | 21.74% |
| 3 | Consumer Staples | 18.93% |
| 4 | Communication Services | 7.49% |
| 5 | Utilities | 6.35% |
Similar funds
KWS
VCM
LN
SCA
PC
HP
JHC
UC
Solel Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Solel Partners held 19 positions worth $264M, up 29% from $204M the previous quarter. Its ten largest holdings account for 86% of the portfolio.
Solel Partners deployed $31.8M of net new capital in Q2 2020, opening 7 new positions and adding to 2 existing holdings. Its largest new stake was Universal Health Services: 240,500 shares worth $22.3M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was HCA Healthcare, an estimated $4.79M trimmed.
- Solel Partners's largest Q2 2020 buy was Universal Health Services: 240,500 shares worth $22.3M.
- Solel Partners added most to PG&E in Q2 2020, an estimated $5.99M increase.
- Solel Partners's biggest Q2 2020 reduction was HCA Healthcare, cutting an estimated $4.79M.
- Solel Partners fully exited Allergan plc in Q2 2020, selling an estimated $39.6M.
- Solel Partners's ten largest holdings make up 86% of its $264M portfolio in Q2 2020.
- Solel Partners opened 7 new positions and closed 4 in Q2 2020.
- Solel Partners's portfolio value rose 29% quarter-over-quarter to $264M.
Based on Solel Partners's 13F filing for Q2 2020, filed 14 Aug 2020.